Adynovate 1000 Unit (Antihemophilic Factor (Recombinant), Pegylated KIT) 1000 UNIT

ADYNOVATE 1000 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This pegylated medication helps manage bleeding episodes and prevent complications.

Strength

1000 UNIT

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADYNOVATE 1000 Unit is primarily used to control and prevent bleeding in individuals with hemophilia B, a genetic disorder that affects blood clotting. It is administered intravenously to replace the missing clotting factor, helping to manage bleeding episodes and support surgical interventions. This medication is designed to provide extended protection against bleeding, making it suitable for both on-demand treatment and routine prophylaxis.

Side Effects

Common effects of ADYNOVATE 1000 Unit may include mild reactions at the injection site, such as redness or swelling. Some individuals might experience headaches, nausea, or fatigue. These effects are generally temporary and subside as the body adjusts to the medication. Severe allergic reactions are rare but require immediate medical attention.

Precautions & Warnings

ADYNOVATE 1000 Unit should be handled with care, ensuring proper storage and administration techniques. It is essential to follow healthcare provider instructions for preparation and use. Individuals with known allergies to any components of the medication should avoid its use. Regular monitoring and consultation with a healthcare professional are recommended to manage potential side effects and ensure optimal treatment outcomes.

Avoid Interactions

ADYNOVATE 1000 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol consumption should be moderated, as it can affect the body's response to the medication. Always consult a healthcare professional before starting or stopping any medication while using ADYNOVATE 1000 Unit.

Frequently Asked Questions

ADYNOVATE 1000 Unit is used to control and prevent bleeding in individuals with hemophilia B.

ADYNOVATE 1000 Unit is administered intravenously, typically by a healthcare professional or trained individual.

Common side effects may include mild reactions at the injection site, headaches, nausea, or fatigue.

Yes, ADYNOVATE 1000 Unit can be used to manage bleeding during surgical procedures in individuals with hemophilia B.

ADYNOVATE 1000 Unit is designed for both short-term and long-term use, depending on the individual's treatment plan.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.